Patent details

EP4267184 Title: INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN

Basic Information

Publication number:
EP4267184
PCT Application Number:
EP2021086689
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP218442283
PCT Publication Number:
WO2022136209
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN
French Title of Invention:
RÉGIME DE DOSAGE DE LA PROTÉINE DE LIAISON DE L'INTERLEUKINE 5
German Title of Invention:
INTERLEUKIN 5 BINDENDES PROTEIN-DOSIERUNGSREGELN
SPC Number:

Dates

Filing date:
20/12/2021
Grant date:
26/11/2025
EP Publication Date:
01/11/2023
PCT Publication Date:
30/06/2022
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/11/2025
EP B1 Publication Date:
26/11/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/12/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/11/2025
 
 

Name:
GlaxoSmithKline Intellectual Property Development Limited
Address:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom (GB)

Inventor

1

Name:
BIRD, Nicholas P
Address:
United Kingdom (GB)

2

Name:
SHUMAN, Melissa A
Address:
United States (US)

3

Name:
AUSTIN, Daren J
Address:
United Kingdom (GB)

4

Name:
POULIQUEN, Isabelle J
Address:
United Kingdom (GB)

5

Name:
MONCK, Myrna A
Address:
United States (US)

Priority

1

Priority Number:
202063128922 P
Priority Date:
22/12/2020
Priority Country:
United States (US)

2

Priority Number:
202163192854 P
Priority Date:
25/05/2021
Priority Country:
United States (US)

3

Priority Number:
202163220182 P
Priority Date:
09/07/2021
Priority Country:
United States (US)

4

Priority Number:
202163285513 P
Priority Date:
03/12/2021
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; C07K 16/24;

Publication

European Patent Bulletin

Issue number:
202548
Publication date:
26/11/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/06/2026
Annual Fee Number:
5
Annual Fee Amount:
52 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages